IRBESARTAN-HYDROCHLOROTHIAZIDE 300-12.5 MG TB

Irbesartan and Hydrochlorothiazide
$0.1947per EA

Strength

12.5; 300 mg/1; mg/1

NDC

62332005290

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA091370

On Market Since

5/23/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price History

1W

0.0%

1M

-2.7%

3M

-6.9%

6M

-2.7%

1Y

-4.5%

3Y

-12.0%

5Y

-35.3%

All

-43.5%